Vyne Therapeutics Inc (NASDAQ:VYNE)

Delayed Data
As of Nov 25
 +0.0005 / +0.22%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 1.50. The median estimate represents a +1,639.13% increase from the last price of 0.23.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Vyne Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.57%
Growthannually 62.43%


Growthquarterly -64.07%
Growthannually -97.51%
Key to the earnings and sales forecast charts.